3.29.22 | Policy OMB Releases Fiscal Year 2023 President’s Budget Request
The president's fiscal year (FY) 2023 budget request serves as an important signaling document for Congress by outlining the administration's priorities for the coming year.
3.28.22 | Policy Women’s Health Policy Agenda Expands Focus Areas for 2022
The 2022 Women’s Health Policy Agenda outlines policy priorities across five key areas—public health, research and clinical trials, lifespan issues, coverage and access, and the biomedical research workforce.
3.28.22 | Diagnostics Assessing and Promoting Bone Health Across the Lifespan
SWHR hosts a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. This event discusses how to improve health outcomes for diseases and conditions that disproportionately affect women, with a focus on bone health.
3.21.22 | Policy Health Policy Outlook for 2022
Members of the Washington, D.C. government affairs firm Thorn Run Partners came to the March Policy Advisory Council meeting to discuss what is on the horizon for health policy in 2022.
3.14.22 | Bone Health Bone Health Roundtable: Importance of Women’s Bone Health Throughout the Lifespan
SWHR convened an interdisciplinary Bone Health Working Group of health care providers, researchers, patient advocates, and policy leaders for a closed, roundtable meeting in April 2022. During the roundtable, the Working Group discussed scientific and policy issues in women’s bone health, including strategies for fracture prevention in at-risk women.
3.9.22 | Policy Congress Unveils Fiscal Year 2022 Omnibus Text
The text of the Consolidated Appropriations Act, 2022 (H.R. 2471) includes emergency funding for COVID-19 and Ukraine, and other provisions.
2.15.22 | Policy SWHR Statement on Dr. Robert Califf Appointment
SWHR released a statement following the Senate’s confirmation of Dr. Robert Califf to serve as the Commissioner of Food and Drugs, Food and Drug Administration.
2.14.22 | Sleep Narcolepsy Program Roundtable: The Impact of Narcolepsy on Women’s Health Across the Lifespan
SWHR convened an interdisciplinary working group to discuss scientific and policy issues around narcolepsy in women, including strategies for better symptom management and how to improve access to treatments and care.
